New Drug Helps Narrow Racial Survival Disparity in Patients with Acute Myeloid Leukemia
Perelman School of Medicine at the University of PennsylvaniaNon-Hispanic Black patients with acute myeloid leukemia (AML) are living longer, now that new therapies are available, according to a study presented by researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition (Abstract 955).